Use of nitric oxide synthase inhibitors for the treatment of...

Details Use of nitric oxide synthase inhibitors for the treatment of... Use of nitric oxide synthase inhibitors for the treatment of...

A - Human Necessities

61

K

A61K 31/195 (2006.01) A61K 31/00 (2006.01) A61K 31/155 (2006.01) A61K 31/198 (2006.01)

Patent

CA 2280871

A method for the treatment and/or prophylaxis of Type II diabetes, which method comprises the administration, to a human or non-human mammal, of an effective non-toxic pharmaceutically acceptable amount of an NO synthase inhibitor, such as aminoguanidine, or a pharmaceutically acceptable derivative thereof.

La présente invention concerne un procédé de traitement et/ou de prophylaxie de diabètes de type II comprenant l'administration, à un humain ou à mammifère non humain, d'une quantité pharmaceutiquement acceptable, non toxique, efficace d'un inhibiteur de ligase du monoxyde d'azote tel qu'une aminoguanadine ou l'un de ses dérivés pharmaceutiquement acceptable.

Affiliated with

Also associated with

Rating

Use of nitric oxide synthase inhibitors for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of nitric oxide synthase inhibitors for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nitric oxide synthase inhibitors for the treatment of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1659284